FPF
KPRX icon

FNY Partners Fund’s Kiora Pharmaceuticals KPRX Stock Holding History

FNY Partners Fund’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed -$8K – 870
2017
Q1 		$8K Buy
+1
New +$11.2K ﹤0.01% 1125

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Partners Fund's KPRX Position: Q2 2017 in Review

FNY Partners Fund sold out of Kiora Pharmaceuticals (KPRX) in Q2 2017, closing a stake of 1 share — an estimated $8K sold.

FNY Partners Fund first reported a position in KPRX in Q1 2017 and held it in 1 quarter. The position peaked at $8K in Q1 2017. 5 funds tracked by Wall St. Rank hold KPRX as of Q2 2017.

  • FNY Partners Fund reported no remaining Kiora Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 1 Kiora Pharmaceuticals share in Q2 2017, an estimated $8K.
  • FNY Partners Fund first reported a position in Kiora Pharmaceuticals in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's Kiora Pharmaceuticals position peaked at $8K in Q1 2017.
  • 5 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.